Results 41 to 50 of about 433 (148)

Macroprolactinemia: new insights in hyperprolactinemia [PDF]

Biochemia Medica, 2012
Hypersecretion of prolactin by lactotroph cells of the anterior pituitary may lead to hyperprolactinemia in physiological, pathological and idiopathic conditions. Most patients with idiopathic hyperprolactinemia may have radiologically undetected microprolactinomas, but some may present other causes of hyperprolactinemia described as macroprolactinemia.
Vlatka Tomic, Vesna Gall, Slavko Orešković, Goran Adzic, Ivana Zec, Davor Jezek, Miro Kasum   +6 more
openaire   +3 more sources

Serum prolactin and macroprolactin levels among outpatients with major depressive disorder following the administration of selective serotonin-reuptake inhibitors: a cross-sectional pilot study. [PDF]

PLoS ONE, 2013
Clinical trials evaluating the rate of short-term selective serotonin-reuptake inhibitor (SSRI)-induced hyperprolactinemia have produced conflicting results.
Sollip Kim, Young-Min Park
doaj   +1 more source

The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients

Kaohsiung Journal of Medical Sciences, 2012
This study investigated the differences in clinical and laboratory features as well as treatment response in 70 outpatients with macroprolactinemia and monomeric hyperprolactinemia treated with dopamine agonists.
Chih-Chin Lu, Ching-Jung Hsieh
doaj   +1 more source

Untreated Giant Macroprolactinoma with Chronic Cerebrospinal Fluid Leakage: An Unusual Complication

Case Reports in Endocrinology, Volume 2019, Issue 1, 2019., 2019
Macroprolactinoma has the potential to cause base of skull erosion and often extends into the sphenoid sinus. Rapid shrinkage of this invasive tumor following dopamine agonist therapy has been postulated to cause unplugging of the eroded area, leading to cerebrospinal fluid leakage.
Mohamad Nazrulhisham Mad Naser, Nor Azizah Aziz, Noor Khairiah A. Karim, Carlo Capella   +3 more
wiley   +1 more source

Emergence of Pituitary Adenoma in a Child during Surveillance: Clinical Challenges and the Family Members’ View in an AIP Mutation‐Positive Family

International Journal of Endocrinology, Volume 2018, Issue 1, 2018., 2018
Introduction. Germline aryl hydrocarbon receptor‐interacting protein (AIP) mutations are responsible for 15–30% of familial isolated pituitary adenomas (FIPAs). We report a FIPA kindred with a heterozygous deletion in AIP, aiming to highlight the indications and benefits of genetic screening, variability in clinical presentations, and management ...
Pedro Marques, Sayka Barry, Amy Ronaldson, Arla Ogilvie, Helen L. Storr, Peter J. Goadsby, Michael Powell, Mary N. Dang, Harvinder S. Chahal, Jane Evanson, Ajith V. Kumar, Joan Grieve, Márta Korbonits, Andrea G. Lania   +13 more
wiley   +1 more source

Stress‐Induced Hyperprolactinemia: Pathophysiology and Clinical Approach

Obstetrics and Gynecology International, Volume 2018, Issue 1, 2018., 2018
While prolactin is most well known for its role in lactation and suppression of reproduction, its physiological functions are quite diverse. There are many etiologies of hyperprolactinemia, including physiologic as well as pathologic causes. Physiologic causes include pregnancy, lactation, sleep‐associated, nipple stimulation and sexual orgasm, chest ...
Samara Levine, Ozgul Muneyyirci-Delale, Curt W. Burger   +2 more
wiley   +1 more source

A macroprolactinemia--da determinação laboratorial ao seu significado clínico.

Acta Médica Portuguesa, 2011
Since prolactin (PRL) (a hormone produced by the anterior pituitary) was first identificated, the existence of hyperprolactinemic syndrome has been recognized.
Catarina Matos, Marias Lopes Pereira, João Tiago Guimarães   +2 more
doaj   +1 more source

The importance of routine screening for macroprolactin in symptomatic patients with idiopathic hyperprolactinemia

Anais da Faculdade de Medicina de Olinda, 2018
Objective: To evaluate the importance of screening for macroprolactin in symptomatic patients with apparent idiopathic hyperprolactinemia. Methods: During 20 months, the prevalence of macroprolactinemia was evaluated among consecutive symptomatic female
Lucio Vilar, Clarice Vilar, José Luciano Albuquerque, Ana Carolina Thé, Patricia Gadelha, Thaíse Borges, Izabela Cardoso, Liana Ferreira, Icaro Sampaio, Maíra Melo, Erik Diniz, Ruy Lyra   +11 more
doaj   +1 more source

Prevalence of Macroprolactinemia in Patients with Hyperprolactinemia Using Roche Elecsys Platform in a Large Tertiary Referral Center in UAE

Dubai Diabetes and Endocrinology Journal, 2021
Objectives: Macroprolactin (macroPRL) excess is an important cause of hyperprolactinemia. Several prolactin assays have high reactivity to macroPRL. However, macroPRL screening is not routinely performed in many labs.
Abdulla Al Nuaimi, Raya Almazrouei, Yusra Othman, Salem Beshyah, Khaled M. Aldahmani   +4 more
doaj   +1 more source

Sexual Dysfunction and Hyperprolactinemia in Male Psychotic Inpatients: A Cross‐Sectional Study

Advances in Urology, Volume 2011, Issue 1, 2011., 2011
Introduction. Sexual dysfunction (SD) and hyperprolactinemia are frequently reported in patients with psychotic disorders and have the potential for severe complications but investigations in males are particularly scarce. The primary aims were to determine the prevalence of SD and hyperprolactinemia in male patients and to investigate whether ...
Erik Johnsen, Rune Kroken, Else-Marie Løberg, Eirik Kjelby, Hugo A. Jørgensen, Hussein Ghanem   +5 more
wiley   +1 more source